Skip to main content
Log in

Careful monitoring required to minimise the damage of amiodarone-induced pulmonary toxicity

  • Drug Reactions and Interactions
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. PDR Generics. 4th ed. Montvale NJ: Medical Economics, 1998: 146–52

  2. ABPI compendium of data sheets and summaries of product characteristics 1998–99. London: Datapharma Publications Ltd, 1998: 1179–81

  3. Rotmensch HH, Liron M, Tupilski M, et al. Possible association of pneumonitis with amiodarone therapy. Am Heart J 1980 Sep; 100(3): 412–3

    Article  PubMed  CAS  Google Scholar 

  4. Martin II WJ, Rosenow III EC. Amiodarone pulmonary toxicity: recognition and pathogenesis. Part I. Chest 1988; 93: 1067–75

    Article  PubMed  Google Scholar 

  5. Jessurun GAJ, Boersma WG, Crijns HJGM. Amiodarone-induced pulmonary toxicity: predisposing factors, clinical symptoms and treatment. Drug Saf 1998 May; 18(5): 339–44

    Article  PubMed  CAS  Google Scholar 

  6. Van Mieghem W, Coolen L, Malysse I, et al. Amiodarone and the development of ARDS after lung surgery. Chest 1994; 105: 1642–5

    Article  PubMed  Google Scholar 

  7. Rotmensch HH, Belhassen B, Swanson B, et al. Steady-state serum amiodarone concentrations: relationship with anti-arrhythmic efficacy and toxicity. Ann Intern Med 1984; 101: 462–9

    PubMed  CAS  Google Scholar 

  8. Mason JW. Toxicity of amiodarone. Circulation 1985; 72 Suppl. 3: 272

    Google Scholar 

  9. Pollak PT, Sharma AD, Carruthers SG. Relation of amiodarone hepatic and pulmonary toxicity to serum drug concentrations and superoxide dismutase activity. Am J Cardiol 1990; 65: 1185–91

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Careful monitoring required to minimise the damage of amiodarone-induced pulmonary toxicity. Drugs Ther. Perspect 12, 14–16 (1998). https://doi.org/10.2165/00042310-199812120-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199812120-00005

Keywords

Navigation